clinivation, Inc.   Log inRegisterContact Us
Company Solutions Clients Resources Partners News Site Map





Announcements

NOVARTIS DIAGNOSTICS SELECTS CLINIVATION WORLDVIEW®.

Innovative leader in making ground-breaking discoveries and developing innovative solutions for the screening and prevention of infectious diseases selects clinivation WorldView as its most comprehensive, authoritative, and up-to-date resource for building its medical product submissions and registrations worldwide.

Natick, MA, January 6, 2010 - clinivation, Inc. announced today Novartis Diagnostics a subsidiary of Novartis AG has selected the clinivation WorldView enterprise solution for On-Demand Global Regulatory Intelligence.

“Novartis Diagnostics is an innovative leader in making ground-breaking discoveries and developing innovative solutions for the screening and prevention of infectious diseases. We are pleased that they have chosen clinivation WorldView for comprehensive, authoritative, and up-to-date global regulatory intelligence,” said Richard Morroney, R.A.C., C.Q.A., clinivation's Vice President, Global Market Clearance Solutions.

About clinivation WorldView On-Demand Global Regulatory Intelligence
Clinivation WorldView is the medical device and diagnostic industry's most comprehensive, authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory Intelligence. Providing clear, step-by-step market clearance regulations, processes, and guidance for >99% of the world markets, only clinivation WorldView delivers tried-and-true intelligence from certified, practicing professionals with real-world experience.
About Novartis Diagnostics
Novartis Diagnostics is a leader in making ground-breaking discoveries and developing innovative solutions for the screening and prevention of infectious diseases. Novartis Diagnostics creates innovative diagnostics to detect, prevent and predict disease and to improve medical outcomes. The company's products are used to test more than 25 million blood donations a year, preventing HIV-1, hepatitis and West Nile Virus transmission through transfusions. Novartis Diagnostics is a subsidiary of Novartis AG.

For more information about Novartis Diagnostics, please visit www.novartisdiagnostics.com.

About clinivation, Inc.
Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global xi market clearance platform, clinivation WorldView on-demand regulatory intelligence, and clinivation Clinical Suite and clinivation Registry Suite electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For further information:
For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.
clinivationPrivacyLegal